[Analysis of Predictive Factors for Discontinuation of Hetrombopag in Patients with Chronic Primary Immune Thrombocytopenia] [0.03%]
评估慢性原发性免疫性血小板减少症患者使用海曲泊帕失败的预测因素分析
Yi Wu,Jiang-Shan Zhao,Xian-Hui Liu
Yi Wu
Objective: To explore the predictive factors and predictive value for sustained response off treatment (SROT) with hetrombopag in patients with chronic primary immune thrombocytopenia (CITP). ...
[Predictive Value of a Risk Assessment Model Based on Coagulation Biomarkers for Venous Thromboembolism after Hematopoietic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia] [0.03%]
[基于凝血生物标志物的儿童急性淋巴细胞白血病造血干细胞移植后静脉血栓栓塞风险评估模型预测价值]
Jia Wei,Fang Chen,Qiu-Xia Tan et al.
Jia Wei et al.
Objective: To construct a risk assessment model for venous thromboembolism (VTE) in children with acute lymphoblastic leukemia (ALL) after transplantation, and to explore the value of this new model in predicting the risk...
[Analysis of Clinical Features and Gene Mutation in Children with Hereditary Coagulation Factor Deficiency] [0.03%]
儿童遗传性凝血因子缺乏症的临床特征和基因突变分析
Qing-Jie Meng,Juan You,Xin Shen et al.
Qing-Jie Meng et al.
Objective: To analyze the clinical features, laboratory tests and gene mutations of children with hereditary coagulation factor deficiency, and explore the correlation between gene mutations and clinical phenotypes. ...
[Validation of the Predictive Ability of IMWG, IMPEDE and SAVED Thrombosis Risk Stratification Systems for Venous Thromboembolism in Chinese Multiple Myeloma Patients] [0.03%]
[IMWG、IMPEDE和SAVED血栓风险评分系统对中国多发性骨髓瘤患者静脉血栓预测能力的验证研究]
Yue Huang,Xing-Yue Wu,Hong-Miao Shen et al.
Yue Huang et al.
Objective: To validate the predictive ability of the International Myeloma Working Group (IMWG) venous thromboembolism (VTE) scoring system, the IMPEDE VTE scoring system, and the SAVED scoring system for VTE in Chinese m...
[Analysis of Clinical Features of Newly Diagnosed Multiple Myeloma Complicated with Light Chain Amyloidosis] [0.03%]
新诊断的多发性骨髓瘤合并轻链淀粉样变患者的临床特征分析
Hong-Miao Shen,Yue Huang,Xing-Yue Wu et al.
Hong-Miao Shen et al.
Objective: To analyze the clinical characteristics of patients with multiple myeloma (MM) complicated with light chain amyloidosis (AL), particularly those with cardiac amyloidosis (CA), in order to provide evidence for e...
[The Clinical Significance and in vitro Experimental Study of hnRNP U in Multiple Myeloma] [0.03%]
hnRNP U在多发性骨髓瘤中的临床意义及实验研究
Wen-Hui Qi,Chun-Li Xu,Li-Li Zhang et al.
Wen-Hui Qi et al.
Objective: To analyze the expression level of heterogeneous nuclear ribonucleoprotein U (hnRNP U) and its correlation with prognosis in patients with multiple myeloma (MM), and explore the functional role as well as molec...
[Multi Model Study and Clinical Decision Analysis of Early Death Risk Warning in Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab] [0.03%]
达雷妥尤单抗新诊断多发性骨髓瘤患者早期死亡风险预警的多模型研究及临床决策分析
Bi-Wei Wang,Hui Sun,Xi Chen et al.
Bi-Wei Wang et al.
Objective: To retrospectively analyze the early death of patients with newly diagnosed multiple myeloma (NDMM) treated with daratumumab, build a risk warning model and verify its clinical decision-making benefits. ...
[Correlation of CD269 Expression Patterns with Antigen Expression and Molecular Cytogenetics Abnormalities in Patients with Multiple Myeloma] [0.03%]
CD269表达模式与多发性骨髓瘤患者抗原表达及分子细胞遗传学异常的相关性分析
Xian-Feng Wang,Meng Shao,Chao Liang et al.
Xian-Feng Wang et al.
Objective: To explore the correlation between CD269 expression patterns in multiple myeloma (MM) cells and the expression of other antigens and molecular cytogenetics. ...
[Impact of TP53 and MYD88 Mutations on Treatment Efficacy in Diffuse Large B-Cell Lymphoma] [0.03%]
[TP53和MYD88基因突变对弥漫大B细胞淋巴瘤疗效影响的研究]
Yi-Ming Yao,Yu-Ye Shi,Yuan Deng et al.
Yi-Ming Yao et al.
Objective: To investigate the relationship between TP53 and MYD88 mutations and treatment efficacy in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based standard chemoimmunotherapy. ...
[Clinicopathological Characteristics of Follicular Lymphoma with a Predominantly Diffuse Growth Pattern] [0.03%]
以弥漫生长为主的滤泡性淋巴瘤的临床病理特征分析
Su-Fen Wang,Jia-Jia Li,Lin-Ming Lu
Su-Fen Wang
Objective: To investigate the clinicopathological features, diagnosis, differential diagnosis, treatment, and prognosis of a patient with follicular lymphoma with predominantly diffuse growth pattern (DFL), in order to en...